PROM1 and medical procedure: Moreover, it was able to induce G2/M phase in hepatocellular carcinoma derived stem cells, CD133+ [71], breast cancerous cells, MDA-MB-231 [53], colorectal cancerous cells, HCT-116 [18] and in renal cancerous cells, ACHN and Caki-1 RCC [67].